المؤلفون: L. Lavalaye, Katja K.H. Aben, I.M. van Oort, Andre M. Bergman, D.M. Somford, J. Van Moorselaar, C.A. Uyl-de Groot, Winald R. Gerritsen, Malou C.P. Kuppen, H.M. Westgeest, A.C.M. van den Bergh, Niven Mehra, A.J.M. van den Eertwegh, Jessica Notohardjo, Jules L.L.M. Coenen, R. de Wit

المصدر: Annals of Oncology. 30:v338-v339

مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, Potential risk, business.industry, Treatment outcome, Population, Hematology, Castration resistant, Abiraterone, chemistry.chemical_compound, Oncology, chemistry, Family medicine, Baseline characteristics, medicine, Prognostic model, In patient, education, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::315c34005976be8e24f0cb8d727d8fbfTest
https://doi.org/10.1093/annonc/mdz248.022Test

المؤلفون: A.J.M. van den Eertwegh, Katja K.H. Aben, Jules L.L.M. Coenen, W R Gerritsen, Niven Mehra, Jules Lavalaye, J. Van Moorselaar, I.M. van Oort, Andre M. Bergman, H.M. Westgeest, A.C.M. van den Bergh, D.M. Somford, R. de Wit, Malou C.P. Kuppen, C.A. Uyl-de Groot

المصدر: Annals of Oncology. 30:v340

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Extent of disease, Hematology, Treatment sequence, Castration resistant, Abiraterone, chemistry.chemical_compound, Oncology, chemistry, Daily practice, Family medicine, Baseline characteristics, medicine, Overall survival, Merck Sharp & Dohme, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c82b566c9b9cf58699fa805d5029e440Test
https://doi.org/10.1093/annonc/mdz248.026Test

المؤلفون: I.M. van Oort, R. Somford, Andre M. Bergman, R. de Wit, J. Van Moorselaar, C.A. Uyl-de Groot, Malou C.P. Kuppen, Katja K.H. Aben, A.J.M. van den Eertwegh, Jules L.L.M. Coenen, Hans M. Westgeest, Niven Mehra, Winald R. Gerritsen, Jules Lavalaye, A.C.M. Van Den Bergh

المساهمون: Medical oncology, CCA - Cancer biology and immunology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life, Urology

المصدر: Westgeest, H M, Kuppen, M, van den Eertwegh, A J M, Van Moorselaar, J, Mehra, N, van Oort, I, van den Bergh, A C M, Coenen, J L, Aben, K K H, Somford, R, de Wit, R, Bergman, A, Lavalaye, J, Uyl-de Groot, C A & Gerritsen, W R 2018, ' Cabazitaxel treatment in metastatic castration-resistant prostate cancer (mCRPC) clinical trials compared to usual care in CAPRI : An observational study in the Netherlands ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii283-viii284 . https://doi.org/10.1093/annonc/mdy284.026Test
Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii283-viii284. Oxford University Press

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, Castration resistant, medicine.disease, Clinical trial, Prostate cancer, Cabazitaxel, Internal medicine, Usual care, medicine, Observational study, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f2854bb7ead411ca59cbc88480dcc8bTest
https://doi.org/10.1093/annonc/mdy284.026Test